Northwestern University Feinberg School of Medicine

Department of Physical Medicine & Rehabilitation

Clinical Trials

Clinica research under the direction of the Department of Physical Medicine and Rehabilitation is conducted through Northwestern University Feinberg School of Medicine. Below you'll find our current clinical trial, including investigator and contact information.

Functional performance evaluation of the Northwestern University Flexible Subischial Vacuum (NU-FlexSIV) Socket for persons with transfemoral amputation
Department of Defense CDMRP Peer Reviewed Orthopaedic Research Program Expansion Award
September 30, 2015-September 29, 2019
Principal Investigator: Stefania Fatone, PhD
https://clinicaltrials.gov/ct2/show/NCT02678247
Longitudinal Observation of Myoelectric Upper Limb Orthosis Use among Veterans with Upper Limb Impairment
Department of Defense CDMRP Orthotics and Prosthetics Outcomes Research Program (OPORP) Orthotics Outcomes Research Award (OORA)
September 30, 2016-September 29, 2019
Principal Investigator: Stefania Fatone, PhD
https://clinicaltrials.gov/ct2/show/NCT03215771

Find additional clinical trials information related to physical medicine and rehabilitation via the Shirley Ryan AbilityLab's clinical trials listing.

Feinberg Clinical Trials

Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.

Trials
Regeneron Knee/Hip OA (1523)
Approximately 10,000 patients will participate in this study to further characterize the safety profile of fasinumab and provide data on long-term exposure to provide efficacy data. In addition to their participation in the main study, approximately 800 patients will par…
Approximately 10,000 patients will participate in this study to further characterize the safety profile of fasinumab and provide data on long-term exposure to provide efficacy data. In addition to their participation in the main study, approximately 800 patients will participate in a sub-study to characterize the onset of pain relief by fasinumab.
At least 18 yrs of age, BMI 39 or less, Osteoarthritis of the knee or hip, taking either Acetaminophen/Tylenol, NSAIDs or opioids at least 4 days a week over last month, fails (either inadequate pain relief, unable to take or refuses to take) Acetaminophen/Tylenol, NSAIDs, and opioids, no rheumatoid arthritis, no fibromyalgia, no symptoms of carpal tunnel syndrome in last 6 months, able to undergo an MRI, is not scheduled for a joint replacement in the next 1.5 yrs, no HIV, no Hepatitis, no sickle cell disease, no S-C disease, no S-beta thalassemia, no heart block, no cancer in last 5 yrs, no hospitalization for depression in last 5 yrs, no alcohol or substance abuse in last 5 yrs, no marijuana use for pain relief in last 6 months, if a female must not become pregnant or breastfeed during the study, and if a female of child-bearing potential must be willing to use contraception during study.
Schnitzer, Thomas JSchnitzer, Thomas J
  • Map it 710 N. Lake Shore Dr. Abbott Hall
    Chicago, IL
NCT02683239 STU00202672
More Info

For more information on this study please contact us:

Sutkus, Loretta
Regeneron 1611
Approximately 3,640 patients will participate in this study to evaluate the efficacy of fasinumab compared to placebo for the treatment of osteoarthritis pain.
At least 18 yrs of age, BMI 39 or less, Osteoarthritis of the knee or hip, taking NSAIDs at least 4 days a week over last month, fails (either inadequate pain relief, unable to take or refuses to take) Acetaminophen/Tylenol, NSAIDs, and opioids, must be able to take naproxen, no rheumatoid arthritis or other inflammatory joint disease, no fibromyalgia, no symptoms of carpal tunnel syndrome in last 6 months, able to undergo an MRI, is not scheduled for a joint replacement in the next 1.5 yrs, no HIV, no Hepatitis, no sickle cell disease, no S-C disease, no S-beta thalassemia, no heart block, no cancer in last 5 yrs, no hospitalization for depression in last 5 yrs, no alcohol or substance abuse in last 5 yrs, no marijuana use for pain relief in last 6 months, if a female must not become pregnant or breastfeed during the study, and if a female of child-bearing potential must be willing to use contraception during study.
Schnitzer, Thomas JSchnitzer, Thomas J
  • Map it 710 N. Lake Shore Dr. Abbott Hall
    Chicago, IL
NCT03161093 STU00205258
More Info

For more information on this study please contact us:

Sutkus, Loretta
DCS in CBP
The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus placebo in relieving the signs and symptoms of patients with chronic lower back pain. This study will last for 26 weeks and will require approximately 6 visits to the study clinic. There will be two gr…
The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus placebo in relieving the signs and symptoms of patients with chronic lower back pain. This study will last for 26 weeks and will require approximately 6 visits to the study clinic. There will be two groups in this study. You will have an equal chance of being in either group. One group will receive D-cycloserine in capsule form and one group will receive placebo in capsule form. All participants have to take two capsules every day, one in the morning and one in the evening. There will be a 1 in 2 chance of receiving placebo.
Must have a history of low back pain for a minimum of 6 months with or without signs and symptoms of radiculopathy
Male or female, age 18 years or older
Must be in generally stable health
Must have a smartphone that will allow downloading of the pain app
Must be willing to abstain from drinking alcohol during the course of the study.
If female, must be post-menopausal for at least one year or practicing an accepted, highly effective method of contraception or abstinence and plan to continue during the course of the study.
Schnitzer, Thomas JSchnitzer, Thomas J
  • Map it 710 N. Lake Shore Dr. Abbott Hall
    Chicago, IL
NCT03535688 STU00205398
More Info

For more information on this study please contact us:

Taira, Ethan
OA pain and TKR
This research study is being done to better understand the causes of knee pain in people with osteoarthritis, and to identify factors that lead to persistent pain after total knee replacement or recovery of knee pain following a total knee replacement. We are also trying to better und…
This research study is being done to better understand the causes of knee pain in people with osteoarthritis, and to identify factors that lead to persistent pain after total knee replacement or recovery of knee pain following a total knee replacement. We are also trying to better understand the changes in brain function, senses, personality and performance abilities after a total knee replacement surgery. Participants will be enrolled in the study for about 13 months and will undergo up to 3 MRI scans of their brain. 
Must have a history of osteoarthritis in a knee and have elected to undergo total knee replacement surgery (TKR) in the knee. Or may have a history of osteoarthritis in a knee and have not elected to undergo a TKR. Must be 40 years or older and be in generally stable health. Must have a smartphone that will allow downloading of a pain app. If female, must be post-menopausal for at least one year or practicing an accepted, highly effective method of contraception or abstinence and plan to continue during the course of the study.
Apkarian, ApkarApkarian, Apkar
  • Map it 710 N. Lake Shore Dr. Abbott Hall
    Chicago, IL
STU00207973
More Info

For more information on this study please contact us:

Shah, Samantha